Subscribe to Search results

Within his witness statement to the Inquiry, Dr Peter Foster advised it was known to be unlikely that PFC would begin production before the end of 1973. Construction began in 1971. It continued until 1974.

Published on:

Within a Blood Products Laboratory report it was explained if PFC processed plasma to produce Factor 8 for England, then less would be needed to be spent on BPL.

Published on:

Professor Tuddenham commented on a legal opinion to the Haemophilia Society, writing "Would the provision of home produced concentrate have reduced the number of HIV infected patients? The answer here must very clearly be 'yes'".

Published on:

Professor Edward Tuddenham was asked within his oral evidence to the Inquiry if it remained his view that if self-sufficiency had been achieved, that a considerable number of cases of AIDS would have been avoided, to which he responded yes.

Published on:

Professor Michael Makris advised within his witness statement to the Inquiry that he believed that, had the UK been self-sufficient in concentrates, the number of HIV infections in haemophilia patients would have been a lot less.

Published on:

Within the minutes of a UK Haemophilia Centre directors meeting it was described by Dr Mayne as limited quantities of concentrate from Elstree and Oxford.

Published on:

Within his written statement to the Inquiry Dr Morris McClelland advised that there were capacity issues at BPL.

Published on:

Table showing annual consumption of Commercial Factor Concentrates.

Published on:

In oral evidence to the Inquiry, Dr Terence Snape apologised for not doing more, sooner.

Published on:

A statement from an investigative reporter investigating Belize's trade in plasma to the US described how a visitor to his motel room told him to take the first plane out the following morning. He left the next day.

Published on:

Cohn fractionation offered a way of separating blood into its constituent parts, and opened the possibility of using that part which was responsible for helping blood to clot without the far greater volume of blood from which it was separated.

Published on:

A lack of close oversight by the DHSS contributed to delays and expense in the redevelopment of BPL.

Published on:

Dr Maycock probably told the Chief Medical Officer that production facilities were not designed for the task nor large enough.

Published on:

A forward-looking interest was taken to updating and renewing production facilities.

Published on:

Additional major investment was needed in the UK if self-sufficiency was to be achieved.

Published on:

Inflation had exceeded 20% in 1975; and GDP had declined in both 1973 and 1975. Unemployment had peaked in 1976 at 1.5 million.

Published on:

Public expenditure increased in 1978-79.

Published on:

Oxford was known to provide a greater quantity of clotting factors than most if not all of the other centres at the time.

Published on:

Figure for the annual consumption of Factor 8 in the UK 23 August 1999.

Published on:

Figure showing annual consumption of CFC 1976 to 1994.

Published on: